Gary E. Schiltz

2.5k total citations · 1 hit paper
52 papers, 1.5k citations indexed

About

Gary E. Schiltz is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Gary E. Schiltz has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Gary E. Schiltz's work include Protein Degradation and Inhibitors (11 papers), Chemical Synthesis and Analysis (6 papers) and HIV/AIDS drug development and treatment (5 papers). Gary E. Schiltz is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Chemical Synthesis and Analysis (6 papers) and HIV/AIDS drug development and treatment (5 papers). Gary E. Schiltz collaborates with scholars based in United States, Philippines and Japan. Gary E. Schiltz's co-authors include Rama K. Mishra, Arun K. Ghosh, Geoffrey Bilcer, Sarki A. Abdulkadir, Jindan Yu, Atul D. Jain, Brian T. Layden, Huiying Han, J. Brandon Parker and Debabrata Chakravarti and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Gary E. Schiltz

49 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy

2019 302 citations Huiying Han, Atul D. Jain et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary E. Schiltz United States	18	910	306	265	185	182	52	1.5k
Johannes Kreuzer United States	15	801 0.9×	277 0.9×	203 0.8×	188 1.0×	242 1.3×	25	1.5k
Xiaobing Deng United States	24	1.2k 1.3×	436 1.4×	138 0.5×	300 1.6×	195 1.1×	39	1.8k
Francesca Musumeci Italy	23	861 0.9×	247 0.8×	577 2.2×	110 0.6×	86 0.5×	65	1.6k
Bianca Sperl Germany	11	819 0.9×	722 2.4×	138 0.5×	145 0.8×	310 1.7×	19	1.5k
Eugenia M. Yazlovitskaya United States	25	1.2k 1.4×	423 1.4×	126 0.5×	278 1.5×	120 0.7×	48	1.9k
Ciro Mercurio Italy	24	1.4k 1.6×	469 1.5×	298 1.1×	137 0.7×	90 0.5×	52	1.9k
Xiaojing Shi China	23	1.4k 1.5×	255 0.8×	538 2.0×	303 1.6×	150 0.8×	51	2.2k
Yanling Wu China	19	934 1.0×	252 0.8×	110 0.4×	115 0.6×	266 1.5×	41	1.4k
Weisheng Xu United States	6	1.8k 2.0×	466 1.5×	150 0.6×	104 0.6×	108 0.6×	6	2.0k

Countries citing papers authored by Gary E. Schiltz

Since Specialization

Citations

This map shows the geographic impact of Gary E. Schiltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Schiltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Schiltz more than expected).

Fields of papers citing papers by Gary E. Schiltz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary E. Schiltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Schiltz. The network helps show where Gary E. Schiltz may publish in the future.

Co-authorship network of co-authors of Gary E. Schiltz

This figure shows the co-authorship network connecting the top 25 collaborators of Gary E. Schiltz. A scholar is included among the top collaborators of Gary E. Schiltz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary E. Schiltz. Gary E. Schiltz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malik, Neha, Isabelle Clerc, Joshua Craft, et al.. (2025). Design and Characterization of Inhibitors of Cell-Mediated Degradation of APOBEC3G That Decrease HIV-1 Infectivity. Viruses. 17(4). 514–514.

Izquierdo, Javier, Candice Mazewski, Elspeth M. Beauchamp, et al.. (2025). Discovery of Potent and Selective MNK Kinase Inhibitors for the Treatment of Leukemia. Journal of Medicinal Chemistry. 68(5). 5824–5844. 1 indexed citations

Yang, William Y., Qianyu Guo, Zachary R. Chalmers, et al.. (2025). Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitors. Science Advances. 11(29). eadw5228–eadw5228.

Hernández, Vanessa, et al.. (2025). Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cells. European Journal of Medicinal Chemistry. 301. 118228–118228.

Han, Xu, Yang Mei, Rama K. Mishra, et al.. (2023). Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models. Journal of Clinical Investigation. 133(6). 11 indexed citations

Dahl, Russell, Amanda Moore, Hua Zhang, et al.. (2023). Positive Allosteric Modulator of SERCA Pump NDC-1173 Exerts Beneficial Effects in Mouse Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 24(13). 11057–11057. 11 indexed citations

Gritsina, Galina, Ka-wing Fong, Xiaodong Lü, et al.. (2023). Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth. Journal of Clinical Investigation. 133(15). 17 indexed citations

Parker, J. Brandon, Vinay Sagar, Mihai I. Truica, et al.. (2022). A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression. Science Advances. 8(17). eabh3635–eabh3635. 37 indexed citations

Han, Ye, Matthew R. Clutter, Rama K. Mishra, et al.. (2022). Discovery of a small-molecule inhibitor of the TRIP8b–HCN interaction with efficacy in neurons. Journal of Biological Chemistry. 298(7). 102069–102069. 6 indexed citations

10.

Masuho, Ikuo, Dongjun Ren, Wei Lv, et al.. (2022). Effects of Small Molecule Ligands on ACKR3 Receptors. Molecular Pharmacology. 102(3). 128–138. 4 indexed citations

11.

Perez, Ricardo E., Diana Saleiro, Gary E. Schiltz, et al.. (2022). Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1. Molecular Immunology. 147. 1–9. 1 indexed citations

12.

Sima, Livia Elena, Bakhtiyor Yakubov, Sheng Zhang, et al.. (2019). Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin. Molecular Cancer Therapeutics. 18(6). 1057–1068. 17 indexed citations

13.

Han, Huiying, Atul D. Jain, Mihai I. Truica, et al.. (2019). Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. Cancer Cell. 36(5). 483–497.e15. 302 indexed citations breakdown →

14.

Lv, Wei, et al.. (2019). Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands. Bioorganic & Medicinal Chemistry. 27(9). 1824–1835. 6 indexed citations

15.

Condello, Salvatore, Livia Elena Sima, Cristina Ivan, et al.. (2018). Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche. Cancer Research. 78(11). 2990–3001. 50 indexed citations

16.

Wei, Changyong, Richa Bajpai, Horrick Sharma, et al.. (2017). Development of GLUT4-selective antagonists for multiple myeloma therapy. European Journal of Medicinal Chemistry. 139. 573–586. 40 indexed citations

17.

Priyadarshini, Medha, Barton Wicksteed, Gary E. Schiltz, Annette Gilchrist, & Brian T. Layden. (2016). SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets?. Trends in Endocrinology and Metabolism. 27(9). 653–664. 89 indexed citations

18.

Han, Ye, et al.. (2015). Identification of Small-Molecule Inhibitors of Hyperpolarization-Activated Cyclic Nucleotide–Gated Channels. SLAS DISCOVERY. 20(9). 1124–1131. 17 indexed citations

19.

Ghosh, Arun K., Dong-Woo Shin, & Gary E. Schiltz. (2002). Multicomponent Reactions: Synthesis of Spirocyclic Tetrahydropyran Derivatives by Prins Cyclization. Heterocycles. 58(1). 659–659. 15 indexed citations

20.

Ghosh, Arun K., Geoffrey Bilcer, & Gary E. Schiltz. (2001). Syntheses of FDA Approved HIV Protease Inhibitors. Synthesis. 2001(15). 2203–2229. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact